• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Polymyositis, pulmonary fibrosis, and hepatitis C.

作者信息

Weidensaul D, Imam T, Holyst M M, King P D, McMurray R W

机构信息

Health Sciences Center, University of Missouri, Columbia 65212.

出版信息

Arthritis Rheum. 1995 Mar;38(3):437-9. doi: 10.1002/art.1780380324.

DOI:10.1002/art.1780380324
PMID:7880199
Abstract

Polymyositis has been associated with several viral infections, and a spectrum of immune-related diseases may occur with hepatitis C virus (HCV) infection. Both polymyositis and HCV infection may be accompanied by interstitial lung disease; however, no association between polymyositis and HCV infection has been reported previously. We report a new association in a patient with HCV infection: anti-Jo-1 positive polymyositis and interstitial lung disease.

摘要

相似文献

1
Polymyositis, pulmonary fibrosis, and hepatitis C.
Arthritis Rheum. 1995 Mar;38(3):437-9. doi: 10.1002/art.1780380324.
2
Polymyositis, pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection.与丙型肝炎病毒感染相关的多发性肌炎、肺纤维化和恶性淋巴瘤。
Intern Med. 2001 Nov;40(11):1109-12. doi: 10.2169/internalmedicine.40.1109.
3
Interstitial alveolitis as early manifestation of anti-Jo-1 positive polymyositis.间质性肺泡炎作为抗合成酶综合征相关抗Jo-1抗体阳性多肌炎的早期表现
Z Rheumatol. 1993 Sep-Oct;52(5):307-11.
4
Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection.丙型肝炎病毒感染患者出现多发性肌炎、肺纤维化和颅神经病变。
Arthritis Rheum. 1996 Jun;39(6):1074-5. doi: 10.1002/art.1780390634.
5
[Anti-Jo-1-positive polymyositis with interstitial alveolitis and pericardial effusion. Overview of 3 years treatment].[伴间质性肺泡炎和心包积液的抗合成酶综合征相关多肌炎。3年治疗概述]
Wien Klin Wochenschr. 1995;107(19):590-2.
6
[Myositis, polysynovitis and pulmonary fibrosis: anti-Jo-1 syndrome].
Schweiz Med Wochenschr. 1996 Jan 27;126(4):120-3.
7
[The Jo-1 Syndrome--immunological findings and clinical manifestations].[乔-1综合征——免疫学发现与临床表现]
Med Klin (Munich). 2005 Mar 15;100(3):137-42. doi: 10.1007/s00063-005-1010-8.
8
[Polymyositis and Jo-1 syndrome].
Z Rheumatol. 1993 Sep-Oct;52(5):301-6.
9
[Comments with respect to 2 patients with anti-Jo 1 antibodies].[关于2例抗Jo-1抗体患者的评论]
An Med Interna. 1992 Aug;9(8):389-90.
10
[Acute polyarthritis, pulmonary fibrosis and Raynaud's phenomenon disclosing polymyositis with anti-JO-1 antibody associated with Gougerot-Sjögren syndrome].[急性多关节炎、肺纤维化及雷诺现象揭示抗JO-1抗体相关的多发性肌炎合并古-塞综合征]
Rev Med Interne. 1993;14(7):744-5. doi: 10.1016/s0248-8663(05)81248-2.

引用本文的文献

1
Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis.基于生物信息学和二代测序数据分析的特发性肺纤维化潜在差异表达基因研究
Biomedicines. 2023 Nov 21;11(12):3109. doi: 10.3390/biomedicines11123109.
2
Genetics and autoantibodies.遗传学与自身抗体。
Immunol Res. 2013 Jul;56(2-3):206-19. doi: 10.1007/s12026-013-8396-9.
3
Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis.丙型肝炎与肺纤维化:丙型肝炎与肺纤维化。
Hepat Mon. 2011 Feb;11(2):71-3.
4
The lung as a possible target for the immune reaction in myositis.肺部可能成为肌炎免疫反应的靶器官。
Arthritis Res Ther. 2011 Jul 13;13(4):230. doi: 10.1186/ar3347.
5
Syphilitic myositis: a case-based review.梅毒性肌炎:基于病例的综述。
Clin Rheumatol. 2011 May;30(5):729-33. doi: 10.1007/s10067-010-1668-z. Epub 2011 Jan 7.
6
Hepatocellular carcinoma,polymyositis,rhabdomyolysis,and acute renal failure.肝细胞癌、多发性肌炎、横纹肌溶解症和急性肾衰竭。
J Korean Med Sci. 2004 Dec;19(6):891-4. doi: 10.3346/jkms.2004.19.6.891.
7
Values of high-resolution computed tomography and pulmonary function tests in managements of patients with chronic hepatitis C virus infection.高分辨率计算机断层扫描和肺功能测试在慢性丙型肝炎病毒感染患者管理中的价值。
World J Gastroenterol. 2004 Feb 1;10(3):381-4. doi: 10.3748/wjg.v10.i3.381.